HSBC Holdings’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.47M Buy
30,010
+12,299
+69% +$602K ﹤0.01% 1245
2025
Q1
$848K Buy
17,711
+1,243
+8% +$59.5K ﹤0.01% 1411
2024
Q4
$749K Sell
16,468
-4,499
-21% -$205K ﹤0.01% 1582
2024
Q3
$780K Buy
20,967
+2,049
+11% +$76.2K ﹤0.01% 1460
2024
Q2
$567K Sell
18,918
-4,281
-18% -$128K ﹤0.01% 1582
2024
Q1
$675K Buy
23,199
+5,913
+34% +$172K ﹤0.01% 1586
2023
Q4
$475K Sell
17,286
-13,066
-43% -$359K ﹤0.01% 1645
2023
Q3
$681K Sell
30,352
-8,715
-22% -$195K ﹤0.01% 1434
2023
Q2
$1.58M Buy
39,067
+25,241
+183% +$1.02M ﹤0.01% 1221
2023
Q1
$682K Sell
13,826
-31,740
-70% -$1.57M ﹤0.01% 1532
2022
Q4
$1.69M Buy
45,566
+29,808
+189% +$1.11M ﹤0.01% 1405
2022
Q3
$803K Sell
15,758
-8,389
-35% -$427K ﹤0.01% 1551
2022
Q2
$969K Sell
24,147
-37,742
-61% -$1.51M ﹤0.01% 1601
2022
Q1
$2.31M Sell
61,889
-8,875
-13% -$332K ﹤0.01% 1288
2021
Q4
$2.85M Buy
70,764
+1,490
+2% +$60K ﹤0.01% 1205
2021
Q3
$2.59M Buy
69,274
+41,941
+153% +$1.57M ﹤0.01% 1124
2021
Q2
$1.16M Buy
27,333
+9,300
+52% +$393K ﹤0.01% 1348
2021
Q1
$859K Buy
18,033
+10,963
+155% +$522K ﹤0.01% 1380
2020
Q4
$435K Sell
7,070
-17,356
-71% -$1.07M ﹤0.01% 1885
2020
Q3
$1.16M Buy
+24,426
New +$1.16M ﹤0.01% 1137
2020
Q2
Sell
-4,999
Closed -$221K 2346
2020
Q1
$221K Buy
4,999
+166
+3% +$7.34K ﹤0.01% 1830
2019
Q4
$232K Buy
+4,833
New +$232K ﹤0.01% 2189
2018
Q3
Sell
-12,921
Closed -$436K 1976
2018
Q2
$436K Buy
+12,921
New +$436K ﹤0.01% 1587